Private Label Tranexamic Acid SPF 50 Lip Gloss Manufacturer

Most private label manufacturers capable of producing a tranexamic acid SPF 50 lip gloss will accept MOQs in the range of 500 to 2,000 units per SKU, though the exact floor depends on several factors that founders should understand before comparing quotes. The biggest MOQ driver is whether you choose a stock (pre-validated) formula or a fully custom formula. Manufacturers who already have a validated TXA + SPF lip gloss base on the shelf can often go as low as 500 units because their R&D costs are already amortized across many clients. Fully custom development — where the cosmetic chemist team builds your formula from scratch to hit your exact TXA percentage, UV filter blend, viscosity, and shade — typically requires at least 1,000–2,000 units to justify the formulation investment. Packaging is the second major variable. Standard doe-foot wand tubes or squeeze tubes purchased from existing tooling carry no minimum surcharge and pair well with 500-unit runs. Custom-molded applicators or proprietary packaging shapes require tooling (usually $3,000–$8,000) and minimum packaging orders of 5,000–10,000 units from the component supplier — which forces the finished-goods MOQ up even if the manufacturer would otherwise go lower. SPF testing economics also matter. In vivo SPF 50 testing (required by FDA for US market products) costs $3,000–$7,000 as a one-time fee for a given formula. At 500 units, that adds $6–$14 per unit to your cost of goods. At 2,000 units, it's $1.50–$3.50 per unit. Some manufacturers absorb this if they're licensing a validated formula to multiple brands; others pass it through on every custom run. The common mistake first-time founders make is negotiating MOQ without understanding what's driving it. A manufacturer quoting 5,000 units isn't always trying to lock you into a large run — they may simply have a packaging component minimum they can't get around. Ask them to break out the formula MOQ, the packaging component MOQ, and the filling/production MOQ separately. You can sometimes bridge a gap by accepting a stock shade or a stock tube and getting a custom label. AJ Cosmo Labs is one platform where you can filter manufacturers specifically by their low-MOQ capabilities — saving you the time of contacting suppliers who require 10,000-unit runs before they'll even respond to a brief.

The total landed cost of a private label tranexamic acid SPF 50 lip gloss breaks into four buckets: formulation fees, testing fees, per-unit production cost, and packaging. Each one scales differently with volume, and confusing them is the most common budgeting error founders make. Formulation fees range from $0 to $5,000 depending on whether you license a stock formula or commission a custom build. A stock TXA + SPF base licensed from the manufacturer's existing library might carry no separate formulation fee — it's baked into the per-unit price. A fully custom formula typically costs $1,500–$5,000 in development fees, paid upfront, and is non-refundable even if you decide not to move forward after sampling. SPF testing is a mandatory one-time cost for US FDA OTC compliance. In vitro SPF testing (increasingly accepted) runs $1,500–$3,500 per formula. In vivo clinical SPF testing (the gold standard) runs $3,000–$7,000. EU Cosmetics Regulation requires equivalent SPF validation per Colipa/ISO 24444 (in vivo) or ISO 24443 (in vitro). Plan for this as a fixed project cost, not a per-unit cost — it doesn't repeat unless you change the formula. Per-unit production cost (formula + filling + standard packaging) typically falls between $3.00–$5.50 at 2,000+ units and $5.50–$9.00 at 500–1,000 units. The premium at low volume reflects higher per-batch overhead allocation. TXA at 2–3% adds roughly $0.30–$0.80 per unit over a basic gloss base because pharmaceutical-grade tranexamic acid is more expensive than standard cosmetic actives. Mineral SPF actives (zinc oxide, titanium dioxide) add less per-unit cost than chemical UV filters like avobenzone blends, but require micronization to avoid whitening on the lip. Packaging — the tube, doe-foot applicator, cap, outer box, and label — typically runs $0.40–$1.50 per unit for standard components at 1,000-unit packaging orders, and $0.20–$0.70 at 5,000+ units. Custom printed tubes or premium soft-touch finishes push toward the higher end. A realistic all-in budget for a first run of 1,000 units: $2,500 (formulation) + $4,000 (SPF testing) + $6,500 (per-unit production at $6.50 average) + $1,000 (packaging premium) = approximately $14,000–$16,000 total. At retail pricing of $18–$35 for a TXA SPF lip gloss, the margin profile is strong once you clear the one-time testing costs.

The full timeline from initial brief to finished goods for a custom private label tranexamic acid SPF 50 lip gloss is typically 14–20 weeks when building a new formula, or 10–14 weeks when licensing a pre-validated stock base. Here is what happens at each stage and what can compress or extend your schedule. Weeks 1–2 are spent on project scoping: signing the NDA, submitting your product brief (target TXA percentage, SPF level, gloss texture, shade direction, target market), and aligning on the regulatory pathway (FDA OTC vs. EU cosmetics). Don't skip the regulatory alignment step — it determines which UV filters are eligible, which changes the entire formula architecture. Weeks 3–6 are formulation development. The cosmetic chemist team builds prototype batches, balancing the oil/wax matrix for gloss performance against the stability requirements of tranexamic acid (a water-soluble active that must be properly solubilized or encapsulated in a lipid-heavy base) and the UV filter load needed to achieve SPF 50. Expect 1–3 prototype iterations. Founders who are slow to provide feedback at this stage are the single biggest cause of timeline extension. Weeks 7–9 cover client sample review and final formula lock. Once you approve the texture, shade, and performance, the formula is locked for stability and SPF testing — no more changes without restarting the clock. Weeks 10–14 are the critical path for SPF testing and accelerated stability. SPF testing labs typically have 4–8 week turnaround times depending on their backlog. Accelerated stability (3 months compressed to 4–6 weeks at elevated temperature and humidity) runs concurrently. Your Drug Facts panel copy is also reviewed and finalized during this window. Weeks 15–17 involve packaging procurement, label artwork approval, and regulatory submission of the product notification (required in some markets). Weeks 18–20 are the production run itself, QC release testing, and shipment preparation. The most common mistake: ordering custom packaging before formula lock. If the formula changes post-packaging order, you may have 10,000 tubes that don't fit the revised fill weight or applicator. Always lock the formula first, then commit to packaging.

Yes. In the United States, any cosmetic product that carries an SPF claim — regardless of format, whether it's a lip gloss, foundation, moisturizer, or lip balm — is legally classified as an over-the-counter (OTC) drug under the FD&C Act. This is one of the most important regulatory facts a founder must internalize before sourcing a private label SPF lip product. The regulatory pathway is the FDA OTC monograph system, governed by 21 CFR Part 352 (and more recently by the Coronavirus Aid, Relief, and Economic Security (CARES) Act framework, which updated how OTC monographs are administered). For a sunscreen lip gloss to be legally marketed in the US, it must: (1) use only FDA-approved sunscreen active ingredients at the concentrations listed in the monograph (e.g., avobenzone up to 3%, octinoxate up to 7.5%, zinc oxide up to 25%, titanium dioxide up to 25%); (2) carry a Drug Facts panel formatted exactly per 21 CFR 201.66; (3) pass SPF testing per FDA methodology (in vivo human testing or accepted in vitro methods); (4) pass broad-spectrum testing if making a broad-spectrum claim; and (5) be manufactured in an FDA-registered OTC drug facility following current Good Manufacturing Practice (cGMP). This last point — facility registration — is the most common reason a founder ends up with a non-compliant product. Many cosmetic manufacturers are registered only as cosmetic facilities under FDA's Voluntary Cosmetic Registration Program (or the now-mandatory MoCRA registration). They are not registered or equipped for OTC drug manufacturing. If your manufacturer doesn't have a drug establishment registration number, they legally cannot manufacture your SPF 50 lip gloss for US sale. Transexamic acid, in contrast, is regulated purely as a cosmetic active. There is no FDA OTC monograph for TXA — it may not carry drug claims (e.g., 'treats melasma' or 'lightens dark spots') but can be marketed under cosmetic language ('visibly brightens,' 'helps reduce the look of uneven tone'). The combination of a cosmetic active (TXA) and an OTC active (SPF) means the product is regulated as a drug, with the cosmetic active simply being part of the inactive or active cosmetic portion of the formulation. For EU markets, the pathway is different: sunscreen actives are listed in Annex VI of EU Cosmetics Regulation 1223/2009 and the product is regulated as a cosmetic (not a drug), but SPF testing per ISO 24444 (in vivo) or ISO 24443 (in vitro) is still required, and a Cosmetic Product Safety Report (CPSR) by a qualified safety assessor is mandatory before placing the product on the EU market. AJ Cosmo Labs connects founders with manufacturers who are already FDA-registered for OTC drug production, so you don't have to audit facility credentials yourself — the platform surfaces that information upfront.

Stability of tranexamic acid in a lip gloss base is a genuine formulation challenge, and it's one that separates experienced cosmetic chemists from generalist formulators. Tranexamic acid (TXA) is a hydrophilic (water-loving) molecule — it is most naturally stable in aqueous environments. A lip gloss, by contrast, is predominantly lipophilic: it is built on a matrix of waxes (carnauba, candelilla, beeswax), oils (castor oil is the classic), and emollient esters. Getting TXA to not only survive in that environment but deliver meaningful brightening efficacy requires deliberate formulation strategy. The three main approaches cosmetic chemists use are: (1) Micro-emulsion or water-in-oil dispersion — a small aqueous phase is carefully emulsified into the lipid matrix using appropriate emulsifiers, allowing TXA to remain dissolved in its preferred environment while the product is still predominantly oil-based. This is the most technically elegant approach but also the most difficult to stabilize. (2) Powder suspension — TXA in its crystalline or micronized powder form is suspended directly in the wax matrix using a dispersing agent. Efficacy delivery may be lower (the active must dissolve on contact with the lip), but stability is more straightforward. (3) TXA derivatives or encapsulated forms — some ingredient suppliers offer TXA in lipid-compatible or encapsulated formats that improve both stability and skin delivery. These cost more per kilogram but simplify the formulator's job. Stability testing for a TXA lip gloss must include: accelerated stability at 40°C/75% RH for 3 months (equivalent to approximately 2 years real-time); freeze-thaw cycling (typically 5 cycles at -10°C to +25°C) to assess separation or crystallization; photostability testing if the product will be marketed as 'brightening' (TXA can degrade under UV in some formulations); and assay testing to verify that TXA concentration at the labeled percentage is maintained throughout the stability period, not just at Day 0. A manufacturer quoting you without any discussion of TXA stability strategy is a red flag. Ask specifically: 'What is your approach to incorporating tranexamic acid into a lip-gloss matrix, and what stability data do you have from prior batches?' If they can't answer that question with technical specificity, their formula is unlikely to perform consistently over a 24–30 month shelf life. Founders can use the AJ Cosmo Labs app to post their brief with explicit requirements for TXA stability data, filtering responses to only manufacturers who can provide prior stability documentation for TXA in lip or anhydrous formats.

Packaging for a private label tranexamic acid SPF 50 lip gloss at low MOQ (500–2,000 units) is constrained primarily by what's available off-the-shelf from component suppliers, because custom tooling at those volumes is rarely economical. Understanding the options — and the tradeoffs — helps founders make decisions that don't extend lead times or blow budgets. The three most common formats at low MOQ are: (1) Doe-foot wand tube — the classic lip gloss format with a doe-foot applicator built into the cap. Available from stock in 6ml, 8ml, and 10ml sizes from multiple component suppliers in China, Korea, and the US. Minimum packaging order from the component supplier is typically 1,000–3,000 pieces, but manufacturers who carry pre-stocked components can go lower. Custom color matching on the tube is possible at 1,000 units with a setup fee of $100–$300. (2) Squeeze tube with separate applicator — less traditional for gloss but growing in popularity for 'skincare-first' positioning, which suits a TXA + SPF product. Minimum 1,000 units is achievable. Easier to print custom branding via digital label or direct tube printing. (3) Lip balm stick with gloss texture — a hybrid format where the product delivers a glossy finish but in a bullet or twist-up stick. Useful if the brand wants SPF positioning without the sticky-gloss connotation. Stock tooling is widely available; custom shaped molds require 8,000–12,000 unit minimums. Labeling requirements for an OTC drug (SPF 50 product) in the US are strict: the Drug Facts panel must appear on the outer packaging in a specific font size, format, and layout per 21 CFR 201.66. This limits how much of the package exterior is available for branding, which is a design constraint founders often underestimate. Work with a packaging designer who has OTC drug label experience. For EU-sold products, the labeling must include all ingredients in INCI order, a 'period after opening' symbol, the responsible person's address, batch number, and SPF on-pack claim per EU rules — a slightly different set of requirements than the US Drug Facts panel. At 500 units, the most practical path is a manufacturer who stocks standard tubes, applies a custom digital label, and handles all Drug Facts formatting in-house. At 2,000+ units, you gain access to custom color tubes, soft-touch coatings, and foil stamping without paying for full tooling. AJ Cosmo Labs features manufacturers who explicitly list their packaging inventory, so you can match your volume to their stock before committing to a project.

Finding the right manufacturing partner for a product as technically specific as a tranexamic acid SPF 50 lip gloss requires more than a Google search. The combination of OTC drug compliance requirements, TXA formulation expertise, and low-MOQ willingness narrows the field significantly — and vetting poorly can cost a founder $10,000–$20,000 in failed development before they realize the manufacturer wasn't qualified. Start with a non-negotiable filter: FDA OTC drug facility registration. Request the manufacturer's FDA establishment registration number and verify it at accessdata.fda.gov. Any manufacturer who hesitates to provide this for a US-market SPF product is an immediate disqualification. This single step eliminates most cosmetic-only contract manufacturers from contention. Second, ask for a portfolio of prior SPF lip products they have manufactured — not just SPF skincare or sunscreen, but specifically lip gloss or lip balm formats with SPF claims. Ask for SPF test certificates from those prior batches. A manufacturer who has successfully done it before has already solved the wax-matrix stability challenges and has relationships with SPF testing labs. Third, ask specifically about tranexamic acid experience. TXA is not yet as ubiquitous in contract manufacturing as niacinamide or vitamin C. A manufacturer who has never worked with TXA in a lip base is going to have a longer, more expensive development process. Ask: 'Have you formulated with tranexamic acid in an anhydrous or low-water base before? Can you share your solubilization approach?' Fourth, check GMP credentials. ISO 22716 is the cosmetics GMP baseline. For OTC drug production, 21 CFR Part 211 (cGMP for finished pharmaceuticals) or 21 CFR Part 117 (if a food-grade facility for ingestible lip products) may be relevant depending on the manufacturer's setup. Ask for their most recent third-party GMP audit report. Fifth, request a reference from a brand at a similar volume (500–2,000 units). A manufacturer who regularly services high-volume clients but claims to accept low-MOQ orders may deprioritize your run when a 50,000-unit client comes in. Speaking to a founder who has run a 1,000-unit batch with them tells you more than any sales call. The AJ Cosmo Labs app streamlines this entire process. You post a single detailed brief — including your TXA target, SPF level, target market, MOQ, and timeline — and receive responses only from manufacturers on the platform who have been vetted for the relevant credentials. Download AJ Cosmo Labs from the App Store, post your brief, and let qualified manufacturers come to you instead of spending weeks cold-emailing factories that may not be equipped for this product category.